3126. Misbranding of Seconal sodium capsules. U. S. v. Mesirow-Madison Drugs, Inc., and Abe R. Segal. Pleas of nolo contendere. Fine of $250 against each defendant. (F. D. C. No. 28100. Sample Nos. 15871-K to 15873-K, incl.) INFORMATION FILED : January 17, 1950, Northern District of Illinois, against Mesirow-Madison Drugs, Inc., Chicago, 111., and Abe R. Segal, president of the corporation. INTERSTATE SHIPMENT: Between the approximate dates of January 19 and February 11, 1949, from the State of Indiana into the State of Illinois. ALLEGED VIOLATION : On or about March 25 and April 2 and 5, 1949, while the drug was being held for sale after shipment in interstate commerce, the de- fendants caused various quantities of the Seconal sodium capsules to be re- packed into unlabeled envelopes and sold without a prescription, which acts of the defendants resulted in the repackaged capsules being misbranded. NATURE OF CHARGE: Misbranding, Section 502 (b) (1) and (2), the repackaged capsules failed to bear labels containing the name and place of business of the manufacturer, packer, or distributor, and a statement of the quantity of the contents. Further misbranding, Section 502 (d), the capsules contained a chemical derivative of barbituric acid, which derivative has been by the Administrator of the Federal Security Agency, found to be, and by regulations designated as, habit forming; and the repackaged capsules failed to bear a label containing the name, and quantity or proportion of such derivative and in juxtaposition therewith the statement "Warning-May be habit forming." Further misbranding, Section 502 (f) (1), the repackaged capsules bore no labeling containing directions for use. DISPOSITION : May 18, 1950. Pleas of nolo contendere having been entered, the court imposed a fine of $250 against each defendant.